Skip to main content

JANE STREET GROUP, LLC

Position in APGE — Apogee Therapeutics, Inc.

CIK 1595888 NEW YORK, NY

Position in APGE

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$430,708
+$430,708 QoQ
Shares Held
3,245
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#212
of 288 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in APGE Over Time

Shares Held

Position Value (USD)

Derivatives in APGE

reported options exposure · as of Jun 30, 2026
CallValue
$3,557,164
CallShares
26,800
PutValue
$3,915,535
PutShares
29,500

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,364,050,815 across 292 Biotechnology names. APGE ranks #122 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in APGE

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,557,164 26,800
2026-06-30 $3,915,535 29,500
2026-06-30 $430,708 3,245
2026-03-31 $4,696,686 55,800
2026-03-31 $2,693,440 32,000
2025-12-31 $483,072 6,400
2025-12-31 $430,236 5,700
2025-12-31 $920,252 12,192
2025-09-30 $1,410,415 35,500
2025-09-30 $3,084,080 77,626
2025-09-30 $206,596 5,200
2025-06-30 $1,554,794 35,800
2025-06-30 $357,646 8,235
2025-06-30 $321,382 7,400
2025-03-31 $513,401 13,742
2025-03-31 $369,864 9,900
2024-12-31 $688,560 15,200
2024-12-31 $252,229 5,568
2024-12-31 $344,280 7,600
2024-09-30 $2,937,000 50,000
2024-09-30 $1,079,347 18,375
2024-06-30 $2,907,689 73,893
2024-03-31 $3,733,093 56,179
2023-12-31 $374,479 13,403
2023-09-30 $433,263 20,341